2024 annual financial data

Oramed Pharmaceuticals 2024 Operating margin

Oramed Pharmaceuticals 2024 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -12,781,000 USD and net income was -19,103,000 USD.
Operating cash flow was -8,412,000 USD.

Get free Oramed Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-12,781,000 USD
Net income
-19,103,000 USD
Operating cash flow
-8,412,000 USD